| 5 min read
From a bladder transplant to a blood test for Alzheimer's disease, there were a lot of firsts this week. Check them out here along with more industry news. 
| 5 min read
Roche scientists developed novel bead technology to automate mass spectrometry, increasing clinician and patient access to this sensitive diagnostic technology.
| 4 min read
A new method to tag and track different antibody drugs in the same mouse reduces the number of animals needed in preclinical studies.News
| 3 min read
The FDA approved Medtronic’s adaptive deep brain stimulation system, which delivers electrical stimulation in real time based on the brain’s state.
| 3 min read
Back pain affects millions of people worldwide, but a new combination treatment that targets senescent cells in the spine may one day provide relief.
| 5 min read
From an executive order to lower drug prices to GLP-1 drug comparisons and a link between Parkinson’s disease and golf courses, it was a busy industry news week.
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 8 min read
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder.
| 4 min read
During mold infection, a cytokine sends signals to neutrophils to kill invading fungal spores in the lungs, enhancing survival.
| 4 min read
Cancer researchers in biotech and pharma highlight the clinical trials and developments they’re most excited about.
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 9 min read
Chemoproteomic tools are yielding early drug candidates for previously undruggable proteins.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
| 4 min read
The therapy lengthened telomeres and improved immune function in people with telomere biology disorder, showing promise for treating bone marrow failure safely.
| 3 min read
A new compound, Vykat XR, addresses insatiable hunger in the rare genetic condition, offering relief for patients and hope for families.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
| 8 min read
Scientists are turning to breath samples as a way to detect tuberculosis economically and conveniently.
| 3 min read
A new antifungal drug, mandimycin, tackles resistant fungal strains with a never-before-seen mechanism that avoids kidney toxicity.
| 5 min read
What’s stopping major progress in the development of new drugs right now? Biotech leaders and researchers shared their thoughts.
| 4 min read
Landmark women’s health study loses funding, a promising antibody-drug conjugate for breast cancer, a schizophrenia drug setback, and more news from this week.
Page 1 of 30 - 586 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Connecting the gut and liver to enhance drug development
Explore how a dual-organ microphysiological system connects human gut and liver tissue to bridge gaps in predicting how drugs behave in the body.
Turning up the heat: thermal analysis for biotherapeutics
Explore essential thermal stability techniques to ensure the safety, quality, and efficacy of biologic drugs.
Cutting the time and cost out of plasmid generation
Discover a hassle-free path to obtaining long, complex plasmid DNA.
